CARDENE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cardene, and when can generic versions of Cardene launch?
Cardene is a drug marketed by Chiesi and is included in three NDAs. There are six patents protecting this drug.
The generic ingredient in CARDENE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cardene
A generic version of CARDENE was approved as nicardipine hydrochloride by ANI PHARMS on October 28th, 1996.
Summary for CARDENE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 173 |
Clinical Trials: | 9 |
Patent Applications: | 3,538 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CARDENE |
What excipients (inactive ingredients) are in CARDENE? | CARDENE excipients list |
DailyMed Link: | CARDENE at DailyMed |
![CARDENE drug patent expirations Drug patent expirations by year for CARDENE](/p/graph/s/t/CARDENE-patent-expirations.png)
![Drug Prices for CARDENE](/p/graph/drug-price/CARDENE.png)
Recent Clinical Trials for CARDENE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Boston Medical Center | Phase 4 |
National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2 |
University of Cincinnati | Phase 2 |
Pharmacology for CARDENE
Anatomical Therapeutic Chemical (ATC) Classes for CARDENE
US Patents and Regulatory Information for CARDENE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chiesi | CARDENE SR | nicardipine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 020005-003 | Feb 21, 1992 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chiesi | CARDENE | nicardipine hydrochloride | CAPSULE;ORAL | 019488-001 | Dec 21, 1988 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chiesi | CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-002 | Jul 31, 2008 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Chiesi | CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-005 | Nov 7, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Chiesi | CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-004 | Nov 7, 2008 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CARDENE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chiesi | CARDENE | nicardipine hydrochloride | CAPSULE;ORAL | 019488-001 | Dec 21, 1988 | ⤷ Sign Up | ⤷ Sign Up |
Chiesi | CARDENE | nicardipine hydrochloride | INJECTABLE;INJECTION | 019734-001 | Jan 30, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Chiesi | CARDENE | nicardipine hydrochloride | INJECTABLE;INJECTION | 019734-001 | Jan 30, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Chiesi | CARDENE | nicardipine hydrochloride | INJECTABLE;INJECTION | 019734-001 | Jan 30, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CARDENE
See the table below for patents covering CARDENE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2018152 | COMPOSITIONS PHARMACEUTIQUES PRÉMÉLANGÉES PRÊTES À L'EMPLOI (PRE-MIXED, READY-TO-USE PHARMACEUTICAL COMPOSITIONS) | ⤷ Sign Up |
Australia | 2007240820 | Pre-mixed, ready-to-use pharmaceutical compositions | ⤷ Sign Up |
Canada | 1029022 | ⤷ Sign Up | |
Canada | 2649779 | COMPOSITIONS EN BOLUS IV PRE-MELANGEES PRETES A L'EMPLOI ET PROCEDES D'UTILISATION (PRE-MIXED, READY-TO-USE IV BOLUS COMPOSITIONS AND METHODS OFUSE) | ⤷ Sign Up |
Canada | 2895102 | COMPOSITIONS PHARMACEUTIQUES PREMELANGEES PRETES A L'EMPLOI (PRE-MIXED, READY-TO-USE PHARMACEUTICAL COMPOSITIONS) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |